NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球苯酮尿症(PKU)治療市場

Global Market Study on Phenylketonuria Treatment: Industry Sales of Ingredients to Dominate Global Landscape

出版商 Persistence Market Research 商品編碼 1004412
出版日期 內容資訊 英文 260 Pages
商品交期: 2-3個工作天內
價格
全球苯酮尿症(PKU)治療市場 Global Market Study on Phenylketonuria Treatment: Industry Sales of Ingredients to Dominate Global Landscape
出版日期: 2021年02月12日內容資訊: 英文 260 Pages
簡介

本報告提供全球苯酮尿症(PKU)治療市場相關調查,市場概要,市場趨勢,成功因素,需求分析與預測,市場規模的變化與預測,各PKU成分、客戶目標、形狀、銷售管道、地區的詳細趨勢,新型冠狀病毒感染疾病(COVID-19)的影響,市場結構,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 市場概要

第3章 主要市場趨勢

第4章 主要成功因素

第5章 市場背景

第6章 新型冠狀病毒感染疾病(COVID-19)危機分析

第7章 蛋白質成分的生產:分析與預測

第8章 零售價格分析

第9章 全球苯酮尿症(PKU)治療市場:分析與預測

第10章 市場分析與預測:各PKU成分

第11章 市場分析與預測:各客戶目標

第12章 市場分析與預測:各形狀

第13章 市場分析與預測:各銷售管道

第14章 全球苯酮尿症(PKU)治療市場:各地區

第15章 北美的苯酮尿症(PKU)治療市場分析與預測

第16章 南美的苯酮尿症(PKU)治療市場分析與預測

第17章 歐洲的苯酮尿症(PKU)治療市場分析與預測

第18章 南亞的苯酮尿症(PKU)治療市場分析與預測

第19章 東亞的苯酮尿症(PKU)治療市場分析與預測

第20章 大洋洲的苯酮尿症(PKU)治療市場分析與預測

第21章 中東、非洲的苯酮尿症(PKU)治療市場分析與預測

第22章 主要新興國家的苯酮尿症(PKU)治療市場分析與預測

第23章 市場結構分析

第24章 競爭分析

第25章 假設和縮寫

第26章 調查手法

目錄
Product Code: PMRREP14410

Phenylketonuria Treatment Market- Scope of Report

A latest publication by Persistence Market Research on the global phenylketonuria treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for successful growth of the phenylketonuria treatment market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research's study. This research study can support readers to know the demand for phenylketonuria treatment and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the phenylketonuria treatment landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market. Insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the phenylketonuria treatment market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the phenylketonuria treatment industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the phenylketonuria treatment market offers information divided into five important segments - PKU ingredient, targeted customer, form, sales channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

PKU Ingredient

Protein Ingredients

Glycomacropeptide (GMP)

Essential and Non-essential Amino Acids

Finish Products

Glycomacropeptide (GMP)

Essential and non-essential amino acids

Targeted Customer

Protein Ingredients

Consumer Healthcare Companies

Pharmaceutical Companies

Contract Manufacturing Companies (CMOs)

Finish Products

Paediatrics

Adults

Pregnant Women

Form

Protein Ingredient

Powder Blend

Granules

Finish Products

Powder & Granules

Tablets

Capsules

Powder Sachets

Ready-to-Drink

Shakes

Others

Sales Channel

Protein Ingredients

Industry Sales (Ingredients)

Finish Products

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Hypermarkets & Supermarkets

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

MEA

Key Questions Answered in Report

Which geographic regions will continue to remain the most profitable markets for phenylketonuria treatment?

How will changing trends impact the market?

How will the COVID-19 pandemic impact market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the winning strategies of stakeholders in the phenylketonuria treatment market to upscale their position in this landscape?

What are the restraints that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will impact the market?

How can businesses in the phenylketonuria treatment market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the phenylketonuria treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of phenylketonuria treatment market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the phenylketonuria treatment market more accurate and reliable.

Table of Contents

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Innovation / Development Trends

4. Key Success Factors

    4.1. Products Adoption / Usage Analysis

    4.2. Key Product USP/Details Analysis by Players

    4.3. Promotional Strategies by Key Players

    4.4. Key Industry Deals 

    4.5. PKU Ingredient Manufacturers/Suppliers 

    4.6. Key Regulations 

    4.7. Reimbursement Scenario

    4.8. Epidemiology of Phenylketonuria, Key Countries 

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Industry Market Outlook

        5.1.3. Global Phenylketonuria Treatment Market Outlook

        5.1.4. Income Per Capita Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising Prevalence of Phenylketonuria

        5.2.2. Rise in Health Concern

        5.2.3. Increase in R&D funding for Phenylketonuria Treatment

        5.2.4. Regulatory Dynamics

        5.2.5. Cost of Medical Food Treatment

    5.3. Value Chain Analysis 

    5.4. Market Dynamics

        5.4.1. Drivers

        5.4.2. Restraints

        5.4.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By PKU Ingredient

        6.4.2. Revenue By Targeted Customer

        6.4.3. Revenue By Form

        6.4.4. Revenue By Sales Channel

        6.4.5. Revenue By Country

    6.5. 2020 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected recovery Quarter

    6.8. Recovery Scenario - Short term, Midterm and Long Term Impact

7. Global Phenylketonuria Treatment Market, Protein Ingredient Production Volume (Tons per annum, TPA) Analysis 2015-2019 and Forecast, 2020-2030

    7.1. Historical Market Protein Ingredient Production Volume (TPA) Analysis, 2015-2019

    7.2. Current and Future Market Protein Ingredient Production Volume (TPA) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute Units Opportunity Analysis

8. Global Phenylketonuria Treatment Market - Retail Pricing Analysis

    8.1. Regional Retail Pricing Analysis, By Product 

    8.2. Global Average Retail Pricing Analysis Benchmark 

9. Global Phenylketonuria Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    9.1. Protein Ingredients 

        9.1.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

        9.1.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

            9.1.2.1. Y-o-Y Growth Trend Analysis

            9.1.2.2. Absolute $ Opportunity Analysis

    9.2. Final Products 

        9.2.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

        9.2.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

            9.2.2.1. Y-o-Y Growth Trend Analysis

            9.2.2.2. Absolute $ Opportunity Analysis

10. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By PKU Ingredient  

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By PKU Ingredient , 2015-2019

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By PKU Ingredient , 2020-2030

        10.3.1. Protein Ingredients

            10.3.1.1. Glycomacropeptide (GMP)

            10.3.1.2. Essential and non-essential amino acids 

        10.3.2. Finish Products

            10.3.2.1. Glycomacropeptide (GMP)

            10.3.2.2. Essential and non-essential amino acids 

    10.4.  Market Attractiveness Analysis By PKU Ingredient  

11. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Targeted Customer 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) By Targeted Customer, 2015-2019

    11.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Targeted Customer, 2020-2030

        11.3.1. Protein Ingredients 

            11.3.1.1. Consumer Healthcare Companies 

            11.3.1.2. Pharmaceutical Companies

            11.3.1.3. Contract Manufacturing Companies (CMOs)

        11.3.2. Finish Products

            11.3.2.1. Adults

            11.3.2.2. Pediatrics 

            11.3.2.3. Pregnant Women

    11.4. Market Attractiveness Analysis By Targeted Customer

12. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Form 

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) By Form, 2015-2019

    12.3. Current and Future Market Size (US$ Mn) and Forecast By Form, 2020-2030

        12.3.1. Protein Ingredients

            12.3.1.1. Powder Blend 

            12.3.1.2. Granules

        12.3.2. Finish Products

            12.3.2.1. Powder & Granules

            12.3.2.2. Tablets

            12.3.2.3. Capsules

            12.3.2.4. Powder Sachets

            12.3.2.5. Ready-to-Drink

            12.3.2.6. Shake 

            12.3.2.7. Others 

    12.4. Market Attractiveness Analysis By Form

13. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Sales Channel 

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) By Sales Channel, 2015-2019

    13.3. Current and Future Market Size (US$ Mn) and Forecast By Sales Channel, 2020-2030

        13.3.1. Protein Ingredients

            13.3.1.1. Industry Sales (Ingredients)

        13.3.2. Finish Products

            13.3.2.1. Hospital Pharmacies

            13.3.2.2. Retail Pharmacies

            13.3.2.3. Online Pharmacies

            13.3.2.4. Hypermarkets & Supermarkets 

    13.4. Market Attractiveness Analysis By Sales Channel 

14. Global Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Region

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019

    14.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. East Asia

        14.3.5. South Asia

        14.3.6. Oceania

        14.3.7. Middle East and Africa (MEA)

    14.4. Market Attractiveness Analysis By Region

15. North America Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    15.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        15.3.1.  By Country

            15.3.1.1. U.S.

            15.3.1.2. Canada

        15.3.2. By PKU Ingredient  

        15.3.3. By Targeted Customer

        15.3.4. By Form

        15.3.5. By Sales Channel

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Latin America Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019

    16.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030 By Country

        16.3.1. By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By PKU Ingredient  

        16.3.3. By Targeted Customer

        16.3.4. By Form

        16.3.5. By Sales Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Europe Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    17.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        17.3.1.  By Country

            17.3.1.1. Germany

            17.3.1.2. Italy

            17.3.1.3. France

            17.3.1.4. U.K.

            17.3.1.5. Spain

            17.3.1.6. BENELUX

            17.3.1.7. Russia

            17.3.1.8. Rest of Europe

        17.3.2. By PKU Ingredient  

        17.3.3. By Targeted Customer

        17.3.4. By Form

        17.3.5. By Sales Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. South Asia Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    18.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030 By Country

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Thailand

            18.3.1.3. Indonesia

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By PKU Ingredient  

        18.3.3. By Targeted Customer

        18.3.4. By Form

        18.3.5. By Sales Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. East Asia Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    19.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030 By Country

        19.3.1. By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.1. By PKU Ingredient  

        19.3.2. By Targeted Customer

        19.3.3. By Form

        19.3.4. By Sales Channel

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Oceania Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    20.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030 By Country

        20.3.1. By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By PKU Ingredient  

        20.3.3. By Targeted Customer

        20.3.4. By Form

        20.3.5. By Sales Channel

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    21.3. Current Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        21.3.1.  By Country

            21.3.1.1. GCC Countries

            21.3.1.2. Turkey

            21.3.1.3. South Africa

            21.3.1.4. Rest of Middle East and Africa

        21.3.2. By PKU Ingredient  

        21.3.3. By Targeted Customer

        21.3.4. By Form

        21.3.5. By Sales Channel

    21.4. Market Attractiveness Analysis

    21.5. Key Market Participants - Intensity Mapping

    21.6. Drivers and Restraints - Impact Analysis

22. Key and Emerging Countries Phenylketonuria Treatment Market Analysis 2015-2019 and Forecast 2020-2030

    22.1. Introduction

        22.1.1. Market Value Proportion Analysis, By Key Countries

        22.1.2. Global Vs. Country Growth Comparison

    22.2. U.S. Phenylketonuria Treatment Market Analysis

        22.2.1. By PKU Ingredient  

        22.2.2. By Targeted Customer

        22.2.3. By Form

        22.2.4. By Sales Channel

    22.3. Canada Phenylketonuria Treatment Market Analysis

        22.3.1. By PKU Ingredient  

        22.3.2. By Targeted Customer

        22.3.3. By Form

        22.3.4. By Sales Channel

    22.4. Mexico Phenylketonuria Treatment Market Analysis

        22.4.1. By PKU Ingredient  

        22.4.2. By Targeted Customer

        22.4.3. By Form

        22.4.4. By Sales Channel

    22.5. Brazil Phenylketonuria Treatment Market Analysis

        22.5.1. By PKU Ingredient  

        22.5.2. By Targeted Customer

        22.5.3. By Form

        22.5.4. By Sales Channel

    22.6. U.K. Phenylketonuria Treatment Market Analysis

        22.6.1. By PKU Ingredient  

        22.6.2. By Targeted Customer

        22.6.3. By Form

        22.6.4. By Sales Channel

    22.7. Germany Phenylketonuria Treatment Market Analysis

        22.7.1. By PKU Ingredient  

        22.7.2. By Targeted Customer

        22.7.3. By Form

        22.7.4. By Sales Channel

    22.8. France Phenylketonuria Treatment Market Analysis

        22.8.1. By PKU Ingredient  

        22.8.2. By Targeted Customer

        22.8.3. By Form

        22.8.4. By Sales Channel

    22.9. Italy Phenylketonuria Treatment Market Analysis

        22.9.1. By PKU Ingredient  

        22.9.2. By Targeted Customer

        22.9.3. By Form

        22.9.4. By Sales Channel

    22.10. Spain Phenylketonuria Treatment Market Analysis

        22.10.1. By PKU Ingredient  

        22.10.2. By Targeted Customer

        22.10.3. By Form

        22.10.4. By Sales Channel

    22.11. BENELUX Phenylketonuria Treatment Market Analysis

        22.11.1. By PKU Ingredient  

        22.11.2. By Targeted Customer

        22.11.3. By Form

        22.11.4. By Sales Channel

    22.12. Russia Phenylketonuria Treatment Market Analysis

        22.12.1. By PKU Ingredient  

        22.12.2. By Targeted Customer

        22.12.3. By Form

        22.12.4. By Sales Channel

    22.13. China Phenylketonuria Treatment Market Analysis

        22.13.1. By PKU Ingredient  

        22.13.2. By Targeted Customer

        22.13.3. By Form

        22.13.4. By Sales Channel

    22.14. Japan Phenylketonuria Treatment Market Analysis

        22.14.1. By PKU Ingredient  

        22.14.2. By Targeted Customer

        22.14.3. By Form

        22.14.4. By Sales Channel

    22.15. South Korea Phenylketonuria Treatment Market Analysis

        22.15.1. By PKU Ingredient  

        22.15.2. By Targeted Customer

        22.15.3. By Form

        22.15.4. By Sales Channel

    22.16. India Phenylketonuria Treatment Market Analysis

        22.16.1. By PKU Ingredient  

        22.16.2. By Targeted Customer

        22.16.3. By Form

        22.16.4. By Sales Channel

    22.17. ASEAN Phenylketonuria Treatment Market Analysis

        22.17.1. By PKU Ingredient  

        22.17.2. By Targeted Customer

        22.17.3. By Form

        22.17.4. By Sales Channel

    22.18. Australia Phenylketonuria Treatment Market Analysis

        22.18.1. By PKU Ingredient  

        22.18.2. By Targeted Customer

        22.18.3. By Form

        22.18.4. By Sales Channel

    22.19. New Zealand Phenylketonuria Treatment Market Analysis

        22.19.1. By PKU Ingredient  

        22.19.2. By Targeted Customer

        22.19.3. By Form

        22.19.4. By Sales Channel

    22.20. GCC Countries Phenylketonuria Treatment Market Analysis

        22.20.1. By PKU Ingredient  

        22.20.2. By Targeted Customer

        22.20.3. By Form

        22.20.4. By Sales Channel

    22.21. Turkey Phenylketonuria Treatment Market Analysis

        22.21.1. By PKU Ingredient  

        22.21.2. By Targeted Customer

        22.21.3. By Form

        22.21.4. By Sales Channel

    22.22. South Africa Phenylketonuria Treatment Market Analysis

        22.22.1. By PKU Ingredient  

        22.22.2. By Targeted Customer

        22.22.3. By Form

        22.22.4. By Sales Channel

23. Market Structure Analysis

    23.1. Market Analysis by Tier of Companies 

    23.2. Market Concentration

    23.3. Market Share Analysis of Top Players

24. Competition Analysis

    24.1. Competition Dashboard

    24.2. Competition Benchmarking

    24.3. Competition Deep Dive (Tentative) 

        24.3.1. Protein ingredient manufacturers

            24.3.1.1.  Arla Foods Ingredients Group P/S

                24.3.1.1.1. Overview

                24.3.1.1.2. PKU Product Portfolio Analysis

                24.3.1.1.3. Sales Footprint

                24.3.1.1.4. Analyst Commentary

                24.3.1.1.5. Strategy Overview

            24.3.1.2. Archer Daniels Midland Company

                24.3.1.2.1. Overview

                24.3.1.2.2. PKU Product Portfolio Analysis

                24.3.1.2.3. Sales Footprint

                24.3.1.2.4. Analyst Commentary

                24.3.1.2.5. Strategy Overview

            24.3.1.3. BASF SE

                24.3.1.3.1. Overview

                24.3.1.3.2. PKU Product Portfolio Analysis

                24.3.1.3.3. Sales Footprint

                24.3.1.3.4. Analyst Commentary

                24.3.1.3.5. Strategy Overview

            24.3.1.4. Chr. Hansen

                24.3.1.4.1. Overview

                24.3.1.4.2. PKU Product Portfolio Analysis

                24.3.1.4.3. Sales Footprint

                24.3.1.4.4. Analyst Commentary

                24.3.1.4.5. Strategy Overview

            24.3.1.5. Cargill, Incorporated

                24.3.1.5.1. Overview

                24.3.1.5.2. PKU Product Portfolio Analysis

                24.3.1.5.3. Sales Footprint

                24.3.1.5.4. Analyst Commentary

                24.3.1.5.5. Strategy Overview

            24.3.1.6. Seidler Chemical Co, Inc.

                24.3.1.6.1. Overview

                24.3.1.6.2. PKU Product Portfolio Analysis

                24.3.1.6.3. Sales Footprint

                24.3.1.6.4. Analyst Commentary

                24.3.1.6.5. Strategy Overview

        24.3.2. Final product manufacturers

            24.3.2.1. Nestle S.A. (Vitaflo International)

                24.3.2.1.1. Overview

                24.3.2.1.2. PKU Product Portfolio Analysis

                24.3.2.1.3. Sales Footprint

                24.3.2.1.4. Analyst Commentary

                24.3.2.1.5. Strategy Overview

            24.3.2.2. Reckitt Benckiser Group plc. (Mead Johnson & Company, LLC.)

                24.3.2.2.1. Overview

                24.3.2.2.2. PKU Product Portfolio Analysis

                24.3.2.2.3. Sales Footprint

                24.3.2.2.4. Analyst Commentary

                24.3.2.2.5. Strategy Overview

            24.3.2.3. Abbott Laboratories

                24.3.2.3.1. Overview

                24.3.2.3.2. PKU Product Portfolio Analysis

                24.3.2.3.3. Sales Footprint

                24.3.2.3.4. Analyst Commentary

                24.3.2.3.5. Strategy Overview

            24.3.2.4. APR Applied Pharma Research S. A.

                24.3.2.4.1. Overview

                24.3.2.4.2. PKU Product Portfolio Analysis

                24.3.2.4.3. Sales Footprint

                24.3.2.4.4. Analyst Commentary

                24.3.2.4.5. Strategy Overview

            24.3.2.5. Ajinomoto Co., Inc.

                24.3.2.5.1. Overview

                24.3.2.5.2. PKU Product Portfolio Analysis

                24.3.2.5.3. Sales Footprint

                24.3.2.5.4. Analyst Commentary

                24.3.2.5.5. Strategy Overview

            24.3.2.6. VitafriendsPKU

                24.3.2.6.1. Overview

                24.3.2.6.2. PKU Product Portfolio Analysis

                24.3.2.6.3. Sales Footprint

                24.3.2.6.4. Analyst Commentary

                24.3.2.6.5. Strategy Overview

            24.3.2.7. Pristine Organics Pvt. Ltd

                24.3.2.7.1. Overview

                24.3.2.7.2. PKU Product Portfolio Analysis

                24.3.2.7.3. Sales Footprint

                24.3.2.7.4. Analyst Commentary

                24.3.2.7.5. Strategy Overview

25. Assumptions and Acronyms Used

26. Research Methodology

List of Tables

  • Table 01: Global Phenylketonuria Treatment Market Volume (Tons per annum, TPA) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 02: Global Phenylketonuria Treatment Market [Protein Ingredients] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 03: Global Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 04: Global Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 05: Global Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 06: Global Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Form
  • Table 07: Global Phenylketonuria Treatment Market Value [Finish Products] (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Form
  • Table 08: Global Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 09: Global Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 10: Global Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Region
  • Table 11: Global Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Region
  • Table 12: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 13: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 14: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 15: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030 2015-2030, By Form
  • Table 16: North America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 17: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 18: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 19: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 20: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030 2015-2030, By Form
  • Table 21: North America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 22: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 23: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 24: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 25: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Form
  • Table 26: Latin America Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 27: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 28: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 29: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 30: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015-2030, By Form
  • Table 31: Latin America Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 32: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 33: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 34: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 35: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Form
  • Table 36: Europe Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 37: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 38: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 39: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 40: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015-2030, By Form
  • Table 41: Europe Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 42: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 43: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 44: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 45: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Form
  • Table 46: South Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 47: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 48: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 49: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 50: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015-2030, By Form
  • Table 51: South Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 52: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 53: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 54: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 55: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Form
  • Table 56: East Asia Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 57: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 58: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 59: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 60: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015-2030, By Form
  • Table 61: East Asia Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 62: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 63: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 64: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 65: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Form
  • Table 66: Oceania Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 67: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 68: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 69: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 70: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015-2030, By Form
  • Table 71: Oceania Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 72: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 73: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 74: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 75: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Form
  • Table 76: Middle East and Africa Phenylketonuria Treatment Market [Protein Ingredient] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel
  • Table 77: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 78: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By PKU Ingredients
  • Table 79: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Targeted Customer
  • Table 80: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis Opportunity Assessment 2015-2030, By Form
  • Table 81: Middle East and Africa Phenylketonuria Treatment Market [Finish Products] Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Sales Channel